Economic Evaluation of Robotic Radiosurgery System for Prostate Cancer Treatments in the Czech Republic
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F19%3A00321389" target="_blank" >RIV/68407700:21460/19:00321389 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/978-981-10-9038-7_20" target="_blank" >http://dx.doi.org/10.1007/978-981-10-9038-7_20</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/978-981-10-9038-7_20" target="_blank" >10.1007/978-981-10-9038-7_20</a>
Alternative languages
Result language
angličtina
Original language name
Economic Evaluation of Robotic Radiosurgery System for Prostate Cancer Treatments in the Czech Republic
Original language description
The purpose of this study was to carry out the economic evaluation of robotic stereotactic body radiation therapy (rSBRT) in comparison with conventional intensity-modulated radiation therapy (IMRT) for the treatment of localized prostate cancer in the Czech Republic. Cost-utility analysis was used for the economic evaluation of both technologies based on their costs and the number of quality-adjusted life years gained (QALYs). Utilities of both technologies were identified in literature. An estimation of treatment costs was obtained from publicly available secondary sources for the Czech Republic. The cost-utility analysis was conducted from provider’s perspective for three scenarios (optimistic, realistic, and pessimistic). According to the results of cost-utility analysis, in every scenario concerned IMRT was both more effective and less costly than rSBRT. Namely, in realistic scenario, IMRT and rSBRT accrued 9.96 QALY/53,198 CZK and 9.93 QALY/79,956 CZK, respectively. rSBRT reached the same or lower values of the cost-utility ratio than IMRT in situation, when the acquisition price of rSBRT equipment was lower than CZK 58 million in the realistic scenario. Under the conditions of the Czech healthcare system, IMRT was more cost-effective than rSBRT for localized prostate cancer treatment in all the analyzed scenarios.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
—
OECD FORD branch
20601 - Medical engineering
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
World Congress on Medical Physics and Biomedical Engineering 2018 (Vol. 2)
ISBN
978-981-10-9037-0
ISSN
1680-0737
e-ISSN
—
Number of pages
6
Pages from-to
113-118
Publisher name
Springer Nature Singapore Pte Ltd.
Place of publication
—
Event location
Prague
Event date
Jun 3, 2018
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
000449742700020